All Stories

  1. PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress

    Article • Hepatology Communications, December 2024, Wolters Kluwer Health

    Dr James L boyer

  2. Primary biliary cholangitis, a rising health burden

    Article • Exploration of Immunology, October 2024, Open Exploration Publishing

    Dr James L boyer

  3. PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases

    Article • Cells, August 2024, MDPI AG

    Dr James L boyer

  4. Bile Acid Induced Inflammation and the Role of β-Catenin

    Article • Cellular and Molecular Gastroenterology and Hepatology, January 2023, Elsevier

    Dr James L boyer

  5. Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

    Article • Hepatology, December 2021, Wolters Kluwer Health

    Dr James L boyer

  6. Letter to the Editor: On the mechanisms of biliary flux

    Article • Hepatology, December 2021, Wolters Kluwer Health

    Dr James L boyer

  7. Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion

    Article • Hepatology, March 2014, Wolters Kluwer Health

    Dr James L boyer

  8. A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis

    Article • Hepatology, June 2012, Wolters Kluwer Health

    Dr James L boyer

  9. Bombesin stimulates bile secretion in calcium-and PKC-independent, pathways

    Article • Gastroenterology, April 1998, Elsevier

    Dr James L boyer